DK0406791T3 - Vandigt flydende præparat til ekstern anvendelse - Google Patents

Vandigt flydende præparat til ekstern anvendelse

Info

Publication number
DK0406791T3
DK0406791T3 DK90112655.7T DK90112655T DK0406791T3 DK 0406791 T3 DK0406791 T3 DK 0406791T3 DK 90112655 T DK90112655 T DK 90112655T DK 0406791 T3 DK0406791 T3 DK 0406791T3
Authority
DK
Denmark
Prior art keywords
aqueous liquid
external use
liquid preparation
methylv
octacos
Prior art date
Application number
DK90112655.7T
Other languages
Danish (da)
English (en)
Inventor
Toshiyasu Honbo
Sachiyo Tanimoto
Hiromitsu Yoshida
Takehisa Hata
Sotoo Asakura
Yasuto Koyama
Youhei Kiyota
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK0406791T3 publication Critical patent/DK0406791T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK90112655.7T 1989-07-05 1990-07-03 Vandigt flydende præparat til ekstern anvendelse DK0406791T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17663789 1989-07-05

Publications (1)

Publication Number Publication Date
DK0406791T3 true DK0406791T3 (da) 1995-03-27

Family

ID=16017063

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90112655.7T DK0406791T3 (da) 1989-07-05 1990-07-03 Vandigt flydende præparat til ekstern anvendelse

Country Status (16)

Country Link
US (1) US5770607A (fr)
EP (1) EP0406791B1 (fr)
JP (1) JP2536248B2 (fr)
KR (1) KR0163035B1 (fr)
CN (1) CN1063322C (fr)
AT (1) ATE117897T1 (fr)
AU (1) AU635286B2 (fr)
CA (1) CA2020431C (fr)
DE (1) DE69016515T2 (fr)
DK (1) DK0406791T3 (fr)
ES (1) ES2066915T3 (fr)
GR (1) GR3014946T3 (fr)
HK (1) HK27097A (fr)
IE (1) IE66485B1 (fr)
IL (1) IL94971A (fr)
ZA (1) ZA905202B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65341B1 (en) * 1990-11-08 1995-10-18 Fujisawa Pharmaceutical Co Suspensions containing tricyclic compounds
EP0582690A1 (fr) * 1991-04-11 1994-02-16 Pfizer Inc. Nouvel agent immunosuppresseur prepare a partir de streptomyces braegensis
US5514686A (en) * 1991-04-26 1996-05-07 Fujisawa Pharmaceutical Co., Ltd. Use of macrolide compounds for eye diseases
CA2071332A1 (fr) * 1991-06-25 1992-12-26 Laszlo R. Treiber Antagonistes du fk-506 hydroxyle en c-21
ZA924953B (en) * 1991-07-25 1993-04-28 Univ Louisville Res Found Method of treating ocular inflammation
DE69230541T2 (de) * 1991-10-31 2000-08-24 Fujisawa Pharmaceutical Co Liposompräparat enthaltend eine tricyclische Verbindung
ATE254450T1 (de) 1995-09-19 2003-12-15 Fujisawa Pharmaceutical Co Aerosolzusammensetzungen
GB9601120D0 (en) 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
ZA9710927B (en) 1996-12-06 1998-06-15 Fujisawa Pharmaceutical Co Pharmaceutical composition.
TW450810B (en) * 1997-02-20 2001-08-21 Fujisawa Pharmaceutical Co Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases
WO1998043643A1 (fr) * 1997-04-01 1998-10-08 Toa Medicine Co., Ltd. Preparations d'une solution aqueuse d'acyclovir
EP1015669B1 (fr) * 1997-04-04 2010-11-17 University Of Southern California Procédé de galvanisation pour la fabrication d'une structure multicouche
WO1999049863A1 (fr) 1998-03-26 1999-10-07 Fujisawa Pharmaceutical Co., Ltd. Preparations a liberation prolongee
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
NZ515339A (en) * 1999-04-30 2004-02-27 R Tech Ueno Ltd Use of macrolide compounds for the treatment of dry eye
US7063857B1 (en) 1999-04-30 2006-06-20 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
JP2001206850A (ja) * 2000-01-25 2001-07-31 Kuraray Co Ltd 眼組織再生誘導剤
US6489335B2 (en) 2000-02-18 2002-12-03 Gholam A. Peyman Treatment of ocular disease
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
GB0108498D0 (en) * 2001-04-04 2001-05-23 Novartis Ag Organic Compounds
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
EP1536793A1 (fr) * 2002-08-09 2005-06-08 Sucampo Pharmaceuticals, Inc. Compositions pharmaceutiques comprenant des derives de fk506, et leur utilisation pour le traitement d'affections allergiques
US7354574B2 (en) * 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US20040198763A1 (en) * 2003-01-16 2004-10-07 Sucampo Ag Method of treating dry eye with a macrolide compound
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
US20050181018A1 (en) * 2003-09-19 2005-08-18 Peyman Gholam A. Ocular drug delivery
US7083803B2 (en) * 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
US20070014760A1 (en) * 2005-07-18 2007-01-18 Peyman Gholam A Enhanced recovery following ocular surgery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430455D0 (en) * 1984-12-03 1985-01-09 Fujisawa Pharmaceutical Co Fr-900506 substance
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
JPS6317884A (ja) * 1986-05-30 1988-01-25 Fujisawa Pharmaceut Co Ltd トリシクロ化合物
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
EP0356399A3 (fr) * 1988-08-26 1991-03-20 Sandoz Ag Dérivés substitués du 4-azatricyclo (22.3.1.04.9) octacos-18-ène, leur préparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
JP2536248B2 (ja) 1996-09-18
KR0163035B1 (ko) 1998-12-01
US5770607A (en) 1998-06-23
CN1063322C (zh) 2001-03-21
ZA905202B (en) 1991-04-24
DE69016515D1 (de) 1995-03-16
EP0406791B1 (fr) 1995-02-01
KR910002454A (ko) 1991-02-25
AU635286B2 (en) 1993-03-18
HK27097A (en) 1997-03-06
ATE117897T1 (de) 1995-02-15
EP0406791A3 (en) 1991-11-06
IL94971A0 (en) 1991-06-10
DE69016515T2 (de) 1995-06-08
CN1048496A (zh) 1991-01-16
JPH03128320A (ja) 1991-05-31
GR3014946T3 (en) 1995-05-31
IL94971A (en) 1995-12-08
IE66485B1 (en) 1996-01-10
EP0406791A2 (fr) 1991-01-09
AU5864290A (en) 1991-01-24
CA2020431C (fr) 2002-09-17
IE902413A1 (en) 1991-06-19
ES2066915T3 (es) 1995-03-16
CA2020431A1 (fr) 1991-01-06

Similar Documents

Publication Publication Date Title
DK0406791T3 (da) Vandigt flydende præparat til ekstern anvendelse
AU653556B2 (en) Suspendible composition and process for preparing the same
DK0474126T3 (fr)
DK0428169T3 (da) Vandige flydende formuleringer
ES2134860T3 (es) Preparacion farmaceutica de accion prolongada.
DE3777223D1 (de) Feste dispersion der substanz fr-900506.
NO902626D0 (no) Fremgangsmaate for stabilisering av biologisk aktive forbindelser immobilisert paa faste faser.
FR2627573B1 (fr) Table elevatrice notamment pour materiels de laboratoire
NO170578C (no) Fremgangsmaate for fremstilling n,n-dimetylaminometylarylforbindelser
ES1007976Y (es) Dispositivo corrector regulable, de la posicion de asido, para utiles escritores.
IT1230844B (it) Procedimento di preparazione di derivati eterociclici.
DK0412464T3 (da) Butalactin, en fremgangsmåde til dets fremstilling og dets anvendelse som lægemiddel
ES1010422Y (es) Contrapunto desplazable perfeccionado para torno de mecanizado.